Edgestream Partners, L.P. Bio Techne Corp Transaction History

Edgestream Partners, L.P.

$2.88 Billion
Q1 2025

A detailed history of Edgestream Partners, L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Edgestream Partners, L.P. holds 198,039 shares of TECH stock, worth $9.57 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

198,039

Previous 13,336 1385.0%

Holding current value

$9.57 Million

Previous $960,000 1109.48%

% of portfolio

0.4%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$58.47 - $78.75 $10.8 Million - $14.5 Million	184,703 Added 1385.0%	198,039 $11.6 Million
Q4 2024 Feb 06, 2025	BUY	$66.37 - $78.17 $885,110 - $1.04 Million	13,336 New	13,336 $960,000
Q2 2024 Aug 09, 2024	SELL	$62.12 - $84.15 $1.28 Million - $1.73 Million	-20,591 Reduced 35.78%	36,956 $2.65 Million
Q1 2024 May 10, 2024	BUY	$65.98 - $77.09 $3.8 Million - $4.44 Million	57,547 New	57,547 $4.05 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $793,022 - $1.05 Million	11,745 New	11,745 $799,000
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $1.3 Million - $1.57 Million	18,173 New	18,173 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $3.12 Million - $4.32 Million	11,033 New	11,033 $3.13 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $1.81 Million - $2.5 Million	-5,127 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$456.15 - $525.06 $2.78 Million - $3.2 Million	-6,099 Reduced 54.33%	5,127 $2.65 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $2.64 Million - $3.2 Million	-5,944 Reduced 34.62%	11,226 $5.44 Million
Q2 2021 Aug 10, 2021	BUY	$387.35 - $450.26 $6.65 Million - $7.73 Million	17,170 New	17,170 $7.73 Million

Others Institutions Holding TECH

# of Institutions

627

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.89B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Bio Techne Corp Transaction History